A less commonly used sepsis biomarker is assessment by flow cytometry of the expression of CD64 on the surface of neutrophils (nCD64) in response to acute systemic inflammatory activation [6], which out-performs both the CRP and Pct in sepsis detection [8]. This evidence concerns the gene FCGR1A and Sepsis.